Hodgkin Lymphoma News and Research

RSS

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

A new study in JNCI Cancer Spectrum finds that dramatic increases in cancer survival in adolescents and young adults are undermined by continuing disparities by race, ethnicity, and socioeconomic status.

12 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Surgery can be beneficial for one type of primary central nervous system lymphoma

Through a systematic review of published studies going back 50 years, Johns Hopkins Medicine researchers say they have identified a distinct subtype of primary central nervous system lymphoma that should be considered for surgical removal, suggesting a major shift in how this type of tumor is evaluated and managed.

From Johns Hopkins Medicine 29 May 2019

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

The German Institute for Quality and Efficiency in Health Care has investigated whether patients suffering from non-Hodgkin lymphoma have (better) chances of recovery when stem cells from another person are transplanted.

24 May 2019

Researchers identify important signaling molecule in the biology of Hodgkin's lymphoma

Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery.

13 May 2019

Patients with advanced Hodgkin's lymphoma may benefit from radiotherapy after chemotherapy

Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy even when all traces of the cancer appear to have gone, according to late breaking results presented at the ESTRO 38 conference today.

29 Apr 2019

Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

In the meta-analysis, Luoping Zhang, University of California, Berkeley, and her team pursued the question of whether people who used plant protection products containing glyphosate had an increased risk of contracting Non-Hodgkin Lymphoma, a form of lymph node cancer.

15 Apr 2019

Popular weed killer’s alleged link to cancer spreads concern

Clumps of dandelions have popped up in your yard, so you reach for a bottle of Roundup, the popular weed killer. It is known for being very effective, but its main ingredient, glyphosate, is getting a lot of attention because of lawsuits alleging links to cancer.

4 Apr 2019

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma.

1 Apr 2019

Second man cured of HIV

A London is now free of HIV/AIDS after a stem cell transplant therapy. This is the second such case after the first case of cured HIV in Berlin.

5 Mar 2019

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma

A new study has shown that the herbicide glyphosphate, could increase the risk of Non-Hodgkin Lymphoma by 41 percent among those who are exposed.

15 Feb 2019

Exposure to chemical in weedkiller Roundup raises risk of some cancers, study finds

Exposure to glyphosate--the world's most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup--increases the risk of some cancers by more than 40 percent, according to new research from the University of Washington.

14 Feb 2019

Low physical fitness during adolescence associated with later receipt of disability pension

Obesity or low physical fitness during adolescence is strongly associated with disability pension later in life. This is shown in a study of more than one million Swedish men, published in Annals of Internal Medicine by researchers at Karolinska Institutet.

12 Feb 2019

New research opens the way for tailored cancer drugs

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.

11 Feb 2019

Study finds low relapse risk in young patients with Hodgkin lymphoma

The treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of their healthy peers.

8 Feb 2019

Cancer among Israeli men on the decline says report

According to a report from the Israel Cancer Association yesterday (3rd February 2019), there has been a significant fall in the number of Israeli men getting cancers over that last decade.

3 Feb 2019

Cancer patients are four times more likely to commit suicide

People with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of Medicine researchers.

14 Jan 2019

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.

24 Dec 2018

Study: Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors

New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of solid tumors many years later.

17 Dec 2018

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy Yescarta remained in remission more than two years following therapy, and more than half of the patients treated remain alive.

4 Dec 2018